VCELVericel Corporation

$2B

FY 2015 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$51M+77.7% YoY

Gross Profit

$25M48.3% margin

Operating Income

-$17M-32.6% margin

Net Income

-$16M-31.9% margin

EPS (Diluted)

$-0.69

Cash Flow

Operating Cash Flow

-$13M

Free Cash Flow

-$16M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$34M

Total Liabilities

$12M

Stockholders' Equity

$22M

Cash & Equivalents

$15M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$51M	$29M	+77.7%
Gross Profit	$25M	$12M	+114.7%
Operating Income	-$17M	-$24M	+29.2%
Net Income	-$16M	-$20M	+18.0%

VCEL FY 2015 Earnings — Vericel Corporation Revenue & Financial Results | Market Cap Arena